DGAP-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Takeover Koblenz, March 25, 2022 - Today, CompuGroup Medical Deutschland AG, a 100 % subsidiary of CompuGroup Medical SE & Co. KGaA (the "Company"), has entered into an agreement with RLPR AG and INSIGHT Health Holding GmbH to acquire all participation in the INSIGHT Health Group. The INSIGHT Health Group, consisting of INSIGHT Health GmbH & Co. KG, its general partner INSIGHT Health Management GmbH and Gesellschaft für statistische Gesundheitsforschung mbH, all based in Waldems, Germany, is active in the field of so-called "market intelligence analysis" of health data. With the transaction, the Company is strengthening its offering in the area of market intelligence analysis of healthcare data. In the financial year 2021, the INSIGHT Health Group generated revenues of approximately EUR 36 million. The purchase price for the 100% participation in the INSIGHT Health Group is between EUR 61 million and EUR 63 million, depending on future corporate developments. These amounts reflect the adjustments for net debt, working capital and trade tax on the capital gain payable by the target companies. The closing of the transaction is subject to merger control clearance by the competent authorities. The closing is expected in the course of the coming months.
25-March-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | CompuGroup Medical SE & Co. KGaA |
Maria Trost 21 | |
56070 Koblenz | |
Germany | |
Phone: | +49 (0)261 8000 7030 |
Fax: | +49 (0)261 8000 3200 |
E-mail: | investor@cgm.com |
Internet: | www.cgm.com |
ISIN: | DE000A288904 |
WKN: | A28890 |
Indices: | MDAX, TecDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1312467 |
End of Announcement | DGAP News Service |
|
1312467 25-March-2022 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.